Intermediate for Apixaban. Apixaban (trade name: Eliquis) is a direct factor Xa inhibitor for the treatment of venous thromboembolic events. Apixaban has been approved by the U.S Food and Drug Administration on March 18, 2014.
Product Name: 1-(4-Nitrophenyl)-2-piperidinone
CAS Number: 38560-30-4
Molecular Weight:  220.2274
Molecular Formula:  C11H12N2O3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.